Clinical Trial

Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients

Study acronym: Thrombosis
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated November 29, 2023 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the efficacy and safety of edoxaban in the prevention of tumor catheter-related thrombosis (CVC/PICC) in high-risk patients
Trial Details
NCT Number NCT06149533
Lead Sponsor Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions Thrombosis, Venous, Cancer, Catheter Complications
Enrollment 366 participants
Start Date 2023-11-30
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2023-11-29